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Background: Local and regional anesthesia was used in endovascular aortic aneurysm repair (EVAR) shortly after its
introduction, and the feasibility has been documented several times. Nevertheless, locoregional anesthesia has not become
accepted on a large scale, probably owing to a traditional surgical attitude preferring general anesthesia. This study
compared various anesthesia techniques in patients treated with EVAR for infrarenal aortic aneurysms.
Methods: From July 1997 to August 2004, 5557 patients who underwent EVAR repair in 164 centers were enrolled in the
EUROSTAR registry. Data were compared among three groups: a general anesthesia group (GA-G) of 3848 patients
(69%), a regional anesthesia group (RA-G) of 1399 patients (25%), and the local anesthesia group (LA-G) of 310 patients
(6%). Differences in preoperative and operative details among the three study groups were analyzed using the 2 test for
discrete variables and the Kruskal-Wallis test for continuous variables. Multivariate logistic regression analysis was
performed on early complications.
Results: The duration of the operation was reduced in the LA-G (115.7 42.2 minutes) compared with the RA-G (127.6
 52.8 min, P < .0009) and GA-G (133.3  59.1 minutes, P < .0001). Admission to the intensive care unit was
significantly less for LA-G patients (2%) than RA-G (8.3%, P .0004) and GA-G (16.2%, P< .0001), but RA-G still had
a distinct advantage (P< .0001) over GA-G. Hospital stay was significantly shorter in LA-G (3.7 3.1 days [P< .0001]
vs GA-G [P .007] vs RA-G), but RA-G (5.1 7.5 days) still had an advantage (P< .0001) vs GA-G (6.2 8.5 days).
In EUROSTAR, systemic complications were significantly lower both for LA-G (6.6%, P  .0015) and RA-G (9.5%, P
 .0007) than for GA-G (13.0%).
Conclusion:The EUROSTARdata indicate that patients appeared to benefit when a locoregional anesthetic technique was
used for EVAR. Locoregional techniques should be used more often to enhance the perioperative advantage of EVAR in
treating infrarenal aneurysms of the abdominal aorta. ( J Vasc Surg 2006;44:16-21.)Endovascular abdominal aortic aneurysm repair
(EVAR) was first described by Volodos and Parodi in
1991.1 An advantage for morbidity and hospital stay could
be stated soon after EVAR was introduced.2,3 However,
there has been lengthy debate about whether EVAR im-
proves mortality for the treatment of infrarenal aortic an-
eurysms.2,3 As late as 2005, two prospectively randomized
comparative studies demonstrated unequivocally lower
perioperative mortality and morbidity after EVAR com-
pared with the conventional open operation.4,5
Another open question is which type of anesthesia is most
suitable with EVAR. Although EVAR is minimally invasive
compared with the conventional procedure, hardly anything
has changed with respect to the anesthetic technique. A short
time after EVAR was introduced, the feasibility of local anes-
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16thesia and regional anesthesia was documented several
times.6-10 Nevertheless, locoregional anesthesia has not yet
become accepted on a large scale in Europe, probably owing
to a traditional attitude. The incidence of locoregional anes-
thesia differs substantially in the various participating coun-
tries. For the United States, no figures have been published
related to this. It is also possible that the publication of De
Virgilio et al11 contributed to this, since they did not find a
positive effect of local anesthesia with regard to cardiopulmo-
nary morbidity and mortality.
A recent publication reported the results of the AneuRx
Phase II Study. It found that local anesthesia is a safe
method that may reduce recovery times and medical mor-
bidity compared with general and regional anesthesia.12
Verhoeven et al13 published the largest series of EVAR with
local anesthesia up till now and showed that primary use of
local anesthesia is feasible and well-tolerated.
The objective of this study was to compare the three
different anesthesia techniques by using the large number
of cases enrolled in the EUROpean collaborators on Stent
Graft Techniques for Abdominal Aortic Aneurysm Repair
(EUROSTAR) registry.
METHODS
Study design. The current analysis was based on data
of a cohort from the EUROSTAR registry. This multi-
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repair in 164 collaborating European vascular centers (Ap-
pendix, online only). Decision on the type of anesthesia and
endograft used depended entirely on the participating phy-
sicians. No details have been recorded about the reasons
why a physician chooses a specific anesthesia or endograft
type.
Patients were enrolled prospectively and pre-, intra-,
and postoperative details were recorded on standardized
case record forms that were sent to the Data Registry
Center in Eindhoven, The Netherlands, or entered online
at the EUROSTAR website (www.eurostar-online.org;
KIKI medical, Nancy, France). Enrollment forms were
submitted to the data registry before the operation to
prevent selective patient inclusion. Follow-up visits were
scheduled at 1, 6, 12, 18, and 24 months, and annually
thereafter. Reminders for overdue follow-up data were
regularly sent to the participating institutions. Outcome
Table II. Procedure related data
Measurements
GA
(n  3848)
RA
(n  1399)
D2 (neck diameter) 23.8  3.2
(9-40)
24.0  3.2
(13-35)
D3 (AAA diameter) 58.1  10.7
(40-130)
59.4  11.2
(40-145)
H1 (neck length) 27.3  12.6
(3-150)
26.4  11.9
(2-100)
H3 (renal to iliac
bifurcation)
118.3  20.7
(24-130)
116.7  21.9
(40-200)
AAA class D E 549 (14.3) 225 (16.1)
Device type†
Bifurcated 3339 (91.4) 1278 (92.0)
Tapered 226 (6.2) 100 (7.2)
Tube 89 (2.4) 11 (0.8)
Stent-graft‡
Anacondaa 17 (0.4) 9 (0.6)
AneuRxb 664 (17.3) 272 (19.5)
Endologixc 75 (17.3) 39 (2.8)
EVTd 48 (1.2) 23 (1.6)
Excludere 444 (11.6) 233 (16.7)
Fortronf 46 (1.2) 21 (1.4)
Lifepathg 63 (1.6) 50 (3.6)
Talentb 993 (25.9) 424 (30.4)
Zenithh 1477 (38.6) 323 (23.2)
Additional procedure 1239 (32.2) 454 (32.5)
Procedure duration
(min)
133.3  59.1
(30-660)
127.6  52.8
(33-540)
ICU admission 619 (16.2) 116 (8.3)
Hospital stay (days) 6.2  8.5
(1-165)
5.1  7.5
(1-106)
Replaced blood
volume (mL)
574.4  714.6
(35-6000)
643.9  672.1
(100-4500)
Team experience
30/year
1709 (44.4) 867 (62.0)
Values are means  SD (ranges) or with (%).
GA, General anesthesia; RA, regional anesthesia; LA; local anesthesia.
†Number missing: 194, 10, 1 in general, regional, and local anesthesia grou
‡Number missing: 21, 5, 1 in general, regional, and local anesthesia group.
aSulzer Vascutech, Bad Soden, Germany; bMedtronic Inc., Minneapolis, Min
Flagstaff, Ariz; fCordis, Miami, Fla; gEdwards Lifesciences, Irvine, Calif; hCreporting adhered to the guidelines from the Society forVascular Surgery/American Association for Vascular Sur-
gery (SVS/AAVS).
Patient population. From July 1997 to August 2004,
5557 patients who underwent an endovascular AAA repair
were entered in the EUROSTAR registry by 164 centers.
Patients treated with the first generation stent-grafts (Sten-
tor and Vanguard) were excluded in this current analysis.
The 5557 patients were categorized in three groups ac-
cording to anesthesia type used during operation: a general
anesthesia group (GA-G) of 3848 patients (69%), a re-
gional anesthesia group (RA-G) of 1399 patients (25%),
and a local anesthesia group (LA-G) of 310 patients (6%).
The following data were compared and analyzed among
the groups: gender, age, SVS score, AAA diameter, proxi-
mal neck length, type of aneurysm, number of procedures
per center (corresponding to each team’s experience), type
of device used, duration of procedure, hospital stay, inten-
sive care unit (ICU) admission, replaced blood, local and
LA
(n  310)
P
(GA vs RA)
P
(GA vs LA)
P
(RA vs LA)
3.8  3.0
(16-33)
NS NS NS
9.0  11.0
(40-100)
.0001 NS NS
8.3  12.7
(10-117)
.0175 NS .0174
4.0  17.4
(60-190)
.0181 .0001 .0001
28 (9.0) NS .0110 .0018
87 (92.9) NS NS NS
14 (4.5) NS NS NS
8 (2.6) .0002 NS .0066
— NS NS NS
2 (0.65) NS .0001 .0001
2 (0.6) NS NS NS
— NS NS NS
(29.1) .0001 .0001 .0001
15 (4.8) NS .0001 .0005
2 (0.6) NS NS NS
75 (24.3) .0012 NS .0326
23 (39.8) .0001 NS .0001
52 (16.8) NS .0001 .0001
5.7  42.2
(25-340)
.0001 .0001 .0009
6 (2.0) .0001 .0001 .0004
3.7  3.1
(1-24)
.0001 .0001 .0070
7.4  436.3
(10-2000)
NS .0334 .0159
06 (66.5) .0001 .0001 .0340
rd,Murray Hill, NJ; dEVT,Menlo Park, Calif; eWLGore &Associates, Inc,
loomington, Ind.2
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late, aneurysm-related), conversion (early, late), and en-
doleak.
Definitions and outcome variables. Local anesthesia
was defined as infiltration of local anesthetics in the groin.
An additional intravenous sedation or pain therapy were
possible, but not recorded in this registry. Spinal anesthesia
and epidural anesthesia are both defined as regional anes-
thesia. Patients with hostile abdomen, an artificial anus, or
severe obesity were considered to be unfit for open surgery.
Unfit for anesthesia was determined by the anesthetist ac-
cording to the American Society of Anesthesiologists
(ASA) classification (mostly ASA IV). Additional proce-
dures included percutaneous transluminal angioplasty/
stent for stenosis, endarterectomy, iliofemoral bypass, and
femorofemoral bypass. All complications, recording of risk
factors, and classification of ASA status were done accord-
ing the SVS guidelines.14,15
Statistical analysis. Differences in preoperative and op-
erative details among the three study groups were analyzed
using the 2 test and logistic regression for discrete variables
and the Kruskal-Wallis and Wilcoxon rank sum tests for con-
tinuous variables. Logistic regression analysis was performed
on early complications. Regression analysis adjustment oc-
curred for differences in patient characteristics, anatomicmea-
surements, and device-related and center-specific variables
(team experience). P .05 implied statistical significance. All
statistical analyses were performed with SAS 8.00 (SAS Insti-
tute, Cary, NC).
RESULTS
Patient characteristics. The mean age was similar for
GA-G, RA-G, and LA-G, averaging 72 years (range, 41 to
100 years). Male gender was found significantly more often
in RA-G than in GA-G (P  .0039). The distribution
according to ASA classification is shown in Table I (online
only). The patients classified worse were in RA-G (P 
Fig. Kaplan-Meier curves of the freedom of type II endoleak
during follow-up..0001 vs GA-G; P .0001 vs LA-G) and LA-G (P .0320vs GA-G). Risk factors according to the SVS/International
Society of Cardiovascular Surgeons (ISCVS) criteria were
slightly different from the ASA estimation (Table I, online
only). Prior laparotomy had been performed significantly
more often in the GA-G and RA-G. Of the RA-G patients,
33.2% were considered unfit for open surgery compared
with only 19.5% of those in the LA-G. The difference was
the greatest in the patients who were appraised as being
unfit for anesthesia. Only 3.4% in the GA-G were treated
with EVAR compared with 16.3% in the LA-G (P .0001)
and 26.1% in the RA-G.
Measurements. The aneurysm measurements are
listed in Table II. The diameter was largest in the RA-G (P
 .0001 vs GA-G) with 59.4 11.2 mm, and the length of
the neck was shortest (P  .0175 vs GA-G, P  .0174 vs
LA-G) with 26.4 11.9. Aneurysms extending to the iliac
vessels (type D, E) were significantly rarer in the LA-G.
Device type and stent-graft. More tube grafts were
used the GA-G (2.3%, P  .0007) and LA-G (2.6%, P 
.0101) than in RA-G (0.8%). Distinct differences were
evident with respect to anesthesia technique for the stent
brands from different companies (Table II).
Procedure-related data. Additional procedures were
applied more rarely in the LA-G (16.8%) than in the two
other groups (RA-G, 32.5%; GA-G, 32.2%). The duration
of the operation was reduced in the LA-G (115.7  42.2
minutes) compared with the RA-G (127.6 52.8minutes,
P .0009) and GA-G (133.3 59.1 minutes, P .0001).
There were substantial differences in favor of locoregional
techniques of anesthesia with regard to the duration of ICU
care and hospital stay. LA-G was shown to be significantly
better than RA-G and GA-G in this regard (Table II).
Team experience also appeared to play a role in the
choice of the anesthetic technique. Locoregional tech-
niques were more frequently used by high-volume centers
(30 EVAR procedures per year).
Early complications. Final completion angiograms
showed that endoleaks, especially type II endoleaks, were
significantly rarer with LA-G (3.2%, P .0001) and RA-G
(7.3%, P  .0008) than in GA-G (10.4%). In follow-up,
this advantage could not be obtained for locoregional
anesthesia techniques (Fig).
After multivariate analysis adjustment, anesthesia type
was not the only factor influencing the endoleak rate.
Aneurysm size and advanced aged were also independently
associated with the endoleak rate. Device type (tube, ta-
pered, or bifurcated) had no influence on endoleak rate;
however, AneuRx (Medtronic,Minneapolis, Minn), Talent
(Medtronic), and Fortron (Cordis, Miami Lakes, Fla) de-
vices were also associated with elevated risk for endoleak
development.
There were no differences with regard to intraoperative
complications in relation to the anesthetic technique. In
EUROSTAR, systemic complications were clearly rarer
both for LA-G (6.6%, P  .0015) and RA-G (9.5%, P 
.0007) than for GA-G (13.0%). Advantages in procedure
and device-related complications were noticed only for
tion,
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and conversion (Table III).
DISCUSSION
Only few publications have reported on the effect of the
appropriate anesthesia technique for EVAR. Cao et al9
conducted a comparative study between GA and RA which
showed that regional anesthesia had an advantage in hos-
pital stay. De Virgilio et al11 presented a comparison be-
tween LA andGA in 2002 that did not reveal any difference
between the two methods.11 Various studies comparing
the three techniques of anesthesia have been published;
however, a drawback of all of them was that one of the
comparison groups (mostly the LA group) consisted of few
patients (80).6,8,10-13 As early as 2002, Walschot et al16
was able to show in a meta-analysis that GA, with an odds
ratio for death of 5.1 (95% confidence interval, 1.9 to 13.3,
was an independent risk factor for perioperative complica-
tions after EVAR.
The multicenter EUROSTAR registry includes pa-
tients with a large variety of comorbidities. This makes a
registry’s patient population a good reflection of everyday
clinical practice. Because of the large number of included
patients, statistical analysis can be performed with great
statistical power, and analysis of small subgroups is allowed
due to the small confidence intervals; therefore, a more
powerful number for each anesthesia group is available.
For the rating of this study, however, one has to take in
Table III. Early (30-day) complications
GA N  3848
(69%)
Final completion angiogram
Endoleak 682 (17.7)
Proximal 105 (2.7)
Midgraft from prosth. fabric 52 (1.3)
Midgraft of limb prosth. connection 37 (1.0)
Distal 59 (1.5)
Perfusion from lumbar or IMA 400 (10.4)
Perfusion from int. iliac artery 24 (0.6)
Complications intraoperatively
Device-related complications 196 (5.1)
Failure to complete procedure 67 (1.7)
Arterial complications 145 (3.8)
Complications from operation to discharge
Systemic complications 498 (13.0)
Cardiac 142 (3.7)
Pulmonary 86 (2.2)
Renal 87 (2.3)
Sepsis 37 (1.0)
Procedure & device related 105 (2.7)
Access site & lower limb complications 266 (6.9)
Early death 93 (2.4)
Early conversion 42 (1.1)
Early rupture 1 (0.03)
Data are values (%).
GA, General anesthesia; RA, regional anesthesia; LA, local anesthesia.
*Adjusted for patient age, American Society of Anesthesiologist classifica
anesthesia, and aneurysm size.account that more than a half of patients were treated byone single center in the LA-G (177 of 310 patients). The
patients appear to be more selected in LA-G (less complex
aneurysms, less additional procedures). The usage of more
Excluder (W. L. Gore and Assoc, Flagstaff, Ariz) stent-
grafts, without suprarenal fixation, supports this view. Poor
patient compliance, severe obesity, or necessity of iliac
access may be a contraindication for LA.
Mortality. In the current analysis, no advantage for an
anesthetic technique could be demonstrated for early or
late mortality. De Virgilio et al11 (71 patients with LA) and
Parra et al12 (50 patients with LA) were also unable to
demonstrate any difference in mortality rate between the
anesthesia types. The main problem in demonstrating an
advantage of anesthesia technique on patient survival con-
sists in the low mortality rate of the EVAR procedure. To
demonstrate a significant difference, the data volume
would have to be even greater than that available in the
EUROSTAR registry. The infrequent use of LA is another
problem. In the EUROSTAR registry, LA was used in only
6% of the EVAR procedures. In a mathematical compari-
son, however, the smallest group is crucial in obtaining a
statistically significant difference.
This is probably to be the reason why a survival advan-
tage for the patients treated with LA cannot be established
from our data despite the more minimally invasive tech-
nique of anesthesia. Nevertheless, the mortality rates for
locoregional techniques were equal, although very much
 1399
25%)
LA N  310
(6%)
P*
GA vs RA
P*
GA vs LA
P*
RA vs LA
(15.0) 29 (9.3) 0.0496 .0002 .0069
2 (3.7) 8 (2.6) NS NS NS
7 (1.2) 2 (0.6) NS NS NS
4 (1.0) 1 (0.3) NS NS NS
4 (1.7) 1 (0.3) NS NS NS
2 (7.3) 10 (3.2) .0356 .0002 .0043
5 (0.4) — NS NS NS
7 (4.8) 11 (3.6) NS NS NS
4 (1.0) 3 (1.0) NS NS NS
6 (3.3) 6 (2.0) NS NS NS
3 (9.5) 20 (6.6) .0001 .0004 NS
1 (2.9) 3 (1.0) .0006 .0163 NS
5 (1.8) 3 (1.0) NS NS NS
2 (1.6) 7 (2.3) NS NS NS
3 (0.2) 1 (0.3) 0.0432 NS NS
3 (3.1) 2 (0.7) NS .0437 .0376
4 (5.3) 14 (4.6) 0.0059 NS NS
2 (2.3) 6 (1.9) NS NS NS
8 (0.6) 1 (0.3) NS NS NS
— — NS NS NS
Society of Vascular Surgery score, unfitness for open surgery or generalRA N
(
210
5
1
1
2
10
6
1
4
13
4
2
2
4
7
3more seriously ill patients (poorer ASA score) were re-
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Complications. No differences were found in the in-
traoperative complications (device-related complications,
failure to complete procedure, and arterial complications)
related to the anesthesia technique. Nor was it to be ex-
pected in view of the frame of reference in this study. The
technical success of EVAR is thus independent of the
anesthesia technique.
In EUROSTAR, systemic complications up to dis-
charge were clearly rarer both for LA-G (6.6%, P 
.0015) and for RA-G (9.5%, P  .0007) than for GA-G
(13.0%). LA-G shows an advantage, especially in terms
of a reduction of the cardiac complications (P .0213 vs
GA-G) and in terms of less sepsis in RA-G (P  .0121 vs
GA-G). This is in partial contrast to the results of Parra et
al,12 who were also able to demonstrate an advantage of
LA vs GA but found a higher cardiopulmonary morbidity
in RA vs GA.
Endoleaks and hospital stay. It was surprising that
significantly fewer endoleaks (type II) were present at the
end of the procedure in LA-G than in the two other
groups. The reasons for this could be the smaller number
of complex aneurysms in this group or that angiographic
detection is complicated by more active bowel move-
ment. The fewer procedure- and device-related compli-
cations for LA-G may be an effect of the above-men-
tioned selection of patients.
Our figures confirm that the advantage of the shorter
hospitalization and ICU stay for RA-G and LA-G, which
Parra et al,12 previously described, is highly significant.
Consequently, there was doubtless a reduction in costs
from the shorter stay in the ICU and in the hospital, which
is of economic significance.
The possible option for immediate conversion is
regarded as an argument in favor of choosing GA for
EVAR. Early conversion was very rare, amounting to
0.5% for locoregional anesthetic techniques in the
EUROSTAR registry. The question arises whether the
operation has to be carried out in conversion standby in
view of the 1:200 probability. Moreover, conversion is
possible at any time in RA and LA when there is appro-
priate standby.
The main finding of this analysis is that RA had
advantages compared with GA regarding complications,
hospital stay, and ICU admission, although more high-
risk patients were treated in this group. Local anesthesia
has the bias of patient selection, as shown in our study;
however, it is well tolerated and feasible in most selected
patients. An advantage was shown compared with GA for
complications, hospital stay, and ICU admission. These
results should encourage local or regional anesthesia to
be favored for EVAR in infrarenal aortic aneurysms. In
conjunction with the recent published study from Ver-
hoeven et al,13 we favor first the use of LA in adapted
patients and then RA.CONCLUSION
A benefit for the morbidity, hospital stay, and ICU stay
could be documented both for the LA-G and RA-G com-
pared with the GA-G using the data of the EUROSTAR
registry. On the basis of the EUROSTAR data, patients in
whom a locoregional anesthetic technique was used for
EVAR appear to benefit. Ultimately, a prospectively ran-
domized study is necessary to clarify the question of which
method of anesthesia is suitable.
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2002;9:82-9.Submitted Jan 26, 2006; accepted Mar 27, 2006.INVITED COMMENTARYEric L. G. Verhoeven, MD, PhD, Groningen, The N
As demonstrated by the authors, endovascular aneurysm re-
pair (EVAR) is still mostly conducted under general anesthesia,
with only 25% of the patients treated under regional anesthesia and
6% under local anesthesia. This is somewhat surprising because
both local anesthesia and regional anesthesia have been shown to
be feasible and safe.
I do agree with the authors that local anesthesia and regional
anesthesia should be considered more often (after all, they are less
invasive, which is especially interesting for older patients present-
ing with comorbidities), but I disagree with their conclusions
regarding the benefits of local anesthesia/regional anesthesia com-
pared with general anesthesia, in view of the occurrence of biases
related to this type of registry.1 Patient selection for local anesthe-
sia is clearly based not only on anatomic criteria and patient
compliance, but also on institution and surgeon preference. This
preference may be related not only to patients and experience, but
also to the health care system. Fragmenting the data shows that
many of the centers are inexperienced and probably therefore not
considering regional anesthesia/local anesthesia in EVAR. My
estimation is that the 14 largest centers have performed at least
2800 cases (200 cases per center), thus leaving the remaining 150
centers with about 2700 cases in the 7-year study period, or fewer
than 3 cases per year. Also, 177 of 310 local anesthesia cases werelands
we do treat more than 75% under local anesthesia, and general
anesthesia is used very rarely (5%).
Another problem resides in the fact that the registry does not
provide data about conversions from local anesthesia/regional
anesthesia to general anesthesia, nor do we have data about addi-
tional intravenous medication during local anesthesia, such as
sedation or pain medication. This would give us more insight into
the safety and applicability of local anesthesia. The authors do
acknowledge that the local anesthesia group had a more suitable
anatomy (fewer type D/E aneurysms) and fewer additional proce-
dures. This clearly has its effect on all time-related outcomes.
Whether the benefits of local anesthesia need to be studied in
a randomized controlled trial remains to be seen. Indeed, if local
anesthesia is safe and well tolerated in selected patients, I cannot
see why it should not be the first choice, especially in high-risk
patients.
The authors are to be congratulated for bringing up this topic.
Vascular surgeons should use local anesthesia whenever possible to
not lose an advantage to other specialists who will certainly use it as
an argument in the ongoing turf battles.
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Total (N  5557)
GA
n  3848 (69%)
RA
n  1399 (25%)
LA
n  310 (6%)
P
GA vs RA
P
GA vs LA
P
RA vs LA
Male gender (%) 3601 (93.6) 1339 (95.7) 289 (93.2) .0039 NS NS
Age in years (range) 72.2  7.8 (41-100) 72.4  7.4 (45-93) 72.6  7.6 (53-96) NS NS NS
ABI 0.87* (%) 391 (22.5) 260 (24.0) 30 (17.0) NS NS .0411
ASA
I (%) 386 (10.0) 84 (6.0) 30 (9.7)
II (%) 1754 (46.1) 382 (27.5) 123 (39.8)
III (%) 1531 (40.2) 747 (53.7) 131 (42.4)
IV (%) 177 (4.6) 186 (13.4) 26 (8.4)
III and IV (%) 1708 (44.6) 933 (67.1) 157 (50.8) .0001 .0334 .0001
SVS-ISCVS2-3
Diabetes (%) 2.5 6.0% 5.5% .002 NS NS
Smoking (%) 22.8 27.0 25.2 .0014 NS NS
Hypertension (%) 26.5 29.6 23.2 .0234 NS .0235
Hyperlipemia (%) 18.2 19.4 17.1 NS NS NS
Cardiac status (%) 29.2 35.5 33.2 .0001 NS NS
Carotid disease (%) 5.9 6.7 3.9 NS NS NS
Renal status (%) 4.0 7.5 3.2 .0001 NS .008
Pulmonary status (%) 17.1 30.0 21.3 .0001 NS .0024
Sum score SVS-ISCVS
(mean  SD)
4.7  2.9 5.7  3.5 4.2  3.0 .0001 .0057 .0001
Previous laparotomy 1032 (27.0) 377 (26.9) 52 (16.8) NS .0001 .0002
Obesity 1012 (26.4) 394 (28.2) 67 (21.7) NS NS NS
Unfit open surgery 851 (22.3) 463 (33.2) 60 (19.5) 0.0001 .00001 .0001
Unfit anesthesia 129 (3.4) 364 (26.1) 50 (16.3) 0.0001 .0001 .0004
GA,General anesthesia;RA, regional anesthesia; LA, local anesthesia;ABI, ankle-brachial index;ASA, American Society of Anesthesiologists; SVS, Society for
Vascular Surgery; ISCVS, International Society for Cardiovascular Surgery.
*N  1737 in GA, 1085 in RA and 177 in LA.
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Austria: Vienna University Hospital, Vienna.
Belgium: ASZ Aalst, Aalst; Onze Lieve Vrouwe Zieken-
huis, Aalst; A.Z.Middelheim, Antwerpen; Sint Vincentiusz-
iekenhuis, Antwerpen; University Hospital Antwerp UIA/
UZA, Antwerpen; Monica Ziekenhuis/OLV Middelares/
Eeuwfeestkliniek, Antwerpen; St. Augustinus Hospital,
Antwerpen/Wilrijk; Clinique Saint Joseph, Arlon; A.Z. St.
Lucas-St Jozef, Assebroek/Brugge; Hopital Princesse Paola
Aye Reseau Hosp de Medecine Sociale, Baudour; Imelda
Hospital, Bonheiden; A.Z. Klina, Brasschaat; A.Z. St. Jan AV,
Brugge; Hospital Erasme, Brussels; Academisch Ziekenhuis
V.U.B., Brussels; Clinique de l’Europe St. Michel, Brussels;
CHU Brugmann, Brussels; Hopitaux D’ Iris Sud, Brussels;
University Hospital Saint Luc, Bruxelles; Clinique Saint Jean,
Bruxelles; CHU,Charleroi; A.Z. Sint Blasius, Dendermonde;
A.Z. St. Maarten, Duffel; A.Z. St. Dimpna, Geel; St. Jan
Ziekenhuis, Genk; vzw Volkskliniek, Gent; A.Z.Sint-Lucas,
Gent; A.Z. St. Jan Palfijn, Gent; Universitair Ziekenhuis,
Gent; AZ Maria Middelares-St Jozef, Gent; St. Joseph Hos-
pital, Gilly; Hopital de Jolimont, Haint Saint Paul; Regionaal
Ziekenhuis Sint Maria-Roos der koningin, Halle; Virga
Jesseziekenhuis, Hasselt; St. Elisabeth, Herentals; CAZ-St.
Franciskus-ziekenhuis, Heusden-Zolder; Regionaal Zieken-
huis JanYperman, Ieper; V.Z.W.GezondheidszorgOostkust,
Knokke; AZGroenige, CampusO.-L.-Vrouw, Kortrijk; Cen-
tre Hospitalier de Trivoli, La Louviere; University Hospital,
Leuven; Heilig Hart, Leuven; University Hospital, Liege;
Clinique Saint-Joseph, Liege; Notre-Dame des Bruyeres,
Liege-Chenee; Maria Ziekenhuis NoordLimburg Campus
Lommel, Lommel; Clinique Reine Astrid, Malmedy; Onze
Lieve Vrouwziekenhuis, Mechelen; Heilig Hart, Menen;
Fusieziekenhuis Jan Palfijn,Merksem; C.H.R. St JospehWar-
quignies, Mons; De Mont Godinne, Mont Godinne; CHM
CNDT, Mouscron; C.H.R.N., Namur; Clinique St. Elisa-
beth, Namur; Clinique Saint-Pierre, Ottignies; Algemeen
Ziekenhuis Heilige Familie, Reet; Stedelijk Ziekenhuis, Roe-
selare; H.H.R. Hartziekenhuis, Roeselare; C.H.R. Val de
Sambre, Sambreville; St. Trudo Hospital, St.Truiden; St An-
driesziekenhuis, Tielt; Cliniques Notre Dame Et St Georges,
Tournai; C.H.R. de Tournai, Tournai; St. Josef Hospital,
Turnhout; St. Elisabeth, Turnhout; St. Augustinuskliniek,
Veurne; Sint-Josefkliniek, Vilvoorde.
Denmark: Rigshospitalet, Copenhagen; Odense Uni-
versital Hospital, Odense.
France: Hospital Notre Dame, Draguignan; Hopital E.
Herriot, Lyon; Hospital Henri Mondor, Paris Creteil Cedex.
Germany: Surgical University Clinic Bonn, Bonn; Au-
gusta Hospital, Dusseldorf; Stadtischen Kliniken Frankfurt an
Main-Hochst, Frankfurt; Cardioangiologisches Centrum Be-
thanien, Frankfurt; Sankt Katharinen, Frankfurt; Altona Gen-
eral Hospital, Hamburg; Klinikum Kempten-OA gGmbH,
Kempten; Bundeswehrzentral K.H. Koblenz, Koblenz; Park-
Krankenhaus, Leipzig; Philipps-University of Marburg, Mar-
burg;KlinikenRechts der IsarMünchen,Munchen;Klinikum
der Ludwig-Maximilians-Universität München-Innenstadt,
München; Pius Hospital, Oldenburg; University Ulm, Ulm.Greece: Athens University Medical School Psihico,
Athens.
Ireland: St. James Hospital, Dublin.
Israel: Sheba Medical Centre, Tel Aviv.
Italy: Policlinico Monteluce, Perugia; Ospedale S.
Giovanni, Roma, Ospedale di Circolo, Varese.
Luxembourg: Centre Hospitalier de Luxembourg,
Luxembourg.
Monaco: Centre Cardio-Thoracique, Monaco.
Norway: Aker University Hospital, Oslo; Ulleval Hos-
pital, Oslo; University Hospital of Trondheim, Trondheim.
Poland: L’Academie de medecine de Lublin, Lublin;
Medical University of Warsaw, Warsaw; MSWiA Hospital,
Warsaw; Central Military Hospital, Warsaw.
Spain: University Hospital of Barcelona, Barcelona;
Ciutat Sanitaria i Universitaria de Bellvitge, Barcelona;
Hospital Sta.Creu i S.Pau, Barcelona; Hospital de Gipuz-
koa, Donostia; San Sebastian Hospital Juan Canalejo, La
Coruna; USP-Hospital Santa Teresa, La Coruña; Hospital
de Leon, Leon; Hospital Xeral Lugo, Lugo; University
Hospital de la Princesa, Madrid; Virgen de la salud (To-
ledo), Madrid; Hospital Ramon y Cajal, Madrid; Funda-
cion Jimenez Diaz,Clinica de la Conception, Madrid; Uni-
versity Hospital of Getafel, Madrid; H.R. Carlos Haya,
Malaga; University Hospital of Navarra, Pamplona; Hospi-
tal Clinico Valladolid, Valladolid.
Sweden:LundUniversityHospital, Lund; OrebroMedical
Centre Hospital, Orebro; Karolinska Hospital, Stockholm.
Switzerland: Clinic for Cardiovascular Surgery, Bern.
The Netherlands:Medisch Centrum Alkmaar, Alkmaar;
Academisch Medisch Centrum, Amsterdam; Vrije Univer-
siteit Amsterdam, Amsterdam; Onze Lieve Vrouwe Gasthuis,
Amsterdam; Gelre Ziekenhuis Apeldoorn, Apeldoorn; Rijn-
state Ziekenhuis, Arnhem; Amphia Hospital, Breda; Reinier
de Graaf Groep, Delft; Medisch CentrumHaaglanden,West-
einde; Leijenburg Ziekenhuis, Den Haag; Slingerland Ziek-
enhuis, Doetinchem; Albert Schweitzer Hospital locatie Am-
stelwijck, Dordrecht; Ny Smellinghe Hospital, Drachten;
Catharina Ziekenhuis, Eindhoven; Medisch Spectrum
Twente, Enschede; St. Anna Ziekenhuis, Geldrop; Acade-
misch Ziekenhuis Groningen, Groningen; Martini Zieken-
huis, Groningen; Medisch Centrum Leeuwarden, Leeuwar-
den; Academisch Ziekenhuis Maastricht, Maastricht; St.
AntoniusZiekenhuis,Nieuwegein;Canisus-WilhelminaZiek-
enhuis,Nijmegen; AcademischZiekenhuisNijmegen,Nijme-
gen; St. Clara Ziekenhuis, Rotterdam; Dijkzicht Ziekenhuis,
Rotterdam; Franciscus Gasthuis Rotterdam, Rotterdam;
Elisabeth Ziekenhuis, Tilburg; TweeSteden ziekenhuis, Til-
burg; Universitair Medisch Centrum, Utrecht; St. Josef Ziek-
enhuis, Veldhoven; Isala Klinieken Lokatie Sophia, Zwolle.
Turkey: Istanbul Memorial Hospital, Istanbul; Uni-
versity of Istanbul Cerrahpa’a Medical F, Istanbul.
United Kingdom: Royal Bournemouth Hospital,
Bournemouth; Bristol Royal Infirmary, Bristol; Countess of
ChesterHospital,Chester;GartnavelHospital,Glasgow;Hull
Royal Infirmary, Hull; Royal University Hospital, Liverpool;
Withington Hospital, Manchester; Freeman Hospital North-
ern Vascular Centre, New Castle-Upon-Tyne.
